MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment HOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- ARTIDIS AG, the developer of the first nanomechanical technology platform for tissue analytics, and The University of Texas MD...

Houston Dash join Dynamo, MD Anderson in Making Cancer History HOUSTON, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center today announced the Houston Dash will join the institution's efforts toward one goal: end cancer....

Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center - Compelling responses previously reported with ADP-A2M4 in sarcoma - - Use of low-dose radiation intended to enhance antitumor activity - PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 22,...

Summit Medical Group to Implement Altura’s Novel HCP Studies™ Mobile Platform to Support Expanding Patient Access to Clinical Studies MISSION VIEJO, Calif. and BERKELEY HEIGHTS, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Altura, the pioneer in expanding participation in health-related studies by streamlining connections between...

ConverGene Announces Sponsored Research Agreement with MD Anderson CAMBRIDGE, Md., Sept. 18, 2017 (GLOBE NEWSWIRE) -- ConverGene is pleased to announce that it has entered into a collaboration with The University of Texas MD Anderson Cancer Center (“MD Anderson”)...